Roivant Sciences earnings missed by $0.10, revenue fell short of estimates

  • Investing.com
Roivant Sciences earnings missed by $0.10, revenue fell short of estimates

Investing.com - Roivant Sciences (NASDAQ: ROIV ) reported second quarter EPS of $-0.380, $0.10 worse than the analyst estimate of $-0.280. Revenue for the quarter came in at $21.62M versus the consensus estimate of $24.77M.

Roivant Sciences's stock price closed at $11.570. It is up 27.990% in the last 3 months and up 172.240% in the last 12 months.

Roivant Sciences saw 2 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See Roivant Sciences's stock price’s past reactions to earnings here.

According to InvestingPro, Roivant Sciences's Financial Health score is "fair performance".

Check out Roivant Sciences's recent earnings performance , and Roivant Sciences's financials here.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100